A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells

Area of Science:

• Neuroscience
• Stem Cell Biology
• Developmental Biology

Background:

• Purkinje cells are crucial for cerebellar function and are implicated in various neurological disorders.
• Studying Purkinje cells in vitro is essential, but generating them from human pluripotent stem cells has been challenging and difficult to replicate.
• Induced pluripotent stem cell (iPSC) technology provides a promising avenue for creating patient-specific neuronal models.

Purpose of the Study:

• To establish a simplified and reproducible protocol for generating Purkinje cells from human induced pluripotent stem cells (iPSCs).
• To create a more accessible in vitro model for studying cerebellar function and pathology.
• To overcome the limitations of existing methods that are difficult to reproduce.

Main Methods:

• Human iPSCs were treated for 21 days with insulin, fibroblast growth factor 2 (FGF2), and SB431542 (a TGFβ-receptor blocker).
• Cerebellar progenitor cells were identified by specific markers (En1, Atoh1, Ptf1a).
• Purkinje cell progenitors were further matured through dissociation and co-culture with mouse cerebellar cells.

Main Results:

• The protocol efficiently generated En1-positive cerebellar progenitors (up to 90%) within 21 days.
• Distinct cerebellar germinal zone subpopulations (rhombic lip and ventricular zone) were identified by day 35.
• By day 70, 10% of differentiated human cells expressed the Purkinje cell marker calbindin after co-culture.

Conclusions:

• A simplified and reproducible method for generating Purkinje cells from human iPSCs has been developed.
• This protocol enhances cell survival, maturation, and ease of handling, making it more accessible for research.
• The improved model facilitates future studies on cerebellar development, function, and disease mechanisms.